About Rida Mourtada
Rida Mourtada is a president and director at Lytica Therapeutics.
Rida Mourtada first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Rida Mourtada in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Rida Mourtada works with at each company, as listed on that company's latest Form D.
Lytica Therapeutics, Inc. · Form D, Apr 11, 2025